Table 1.
Age and IOP characteristics of subject groups
| Age | IOP before drops | 2 mins after | 5 mins after | |
|---|---|---|---|---|
| Refresh (Control) | ||||
| Eyedrops | ||||
| Average | 21.0 | 15.1 | 15.3 | 15.1 |
| Std Dev | 2.0 | 2.6 | 2.5 | 2.5 |
| p values | p > 0.05 | p > 0.05 | ||
| Novesin | ||||
| Eyedrops | ||||
| Average | 21.1 | 15.7 | 15.1 | 14.9 |
| Std Dev | 2.0 | 3.6 | 3.1 | 3.0 |
| p values | p < 0.01 | p < 0.001 | ||
| Alcaine | ||||
| Eyedrops | ||||
| Average | 21.4 | 16.1 | 15.3 | 15.1 |
| Std Dev | 1.9 | 3.0 | 3.2 | 3.0 |
| p values | p < 0.001 | p < 0.001 | ||
p values are from repeated-measures ANOVA comparisons of IOP 2 minutes and 5 minutes after eyedrop instillation, with the baseline IOP measured before the eyedrop was instilled.